Nasdaq stss.

Nov 10, 2023 · STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales Sharps Technology Inc. Common Stock (STSS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Sharps Technology Earnings & Revenue FAQ. What were STSS's earnings last quarter? On Aug 30, 2023, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings ...US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features.

NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...Short interest for Sharps Technology gives investors a sense of the degree to which investors are betting on the decline of Sharps Technology's stock. Short interest data is updated every two weeks.

STSS Sharps Technology Inc Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400

... Nasdaq Rules. offering. IMPACT. SENTIMENT. 11/16/2023 08:00 AM. RVPH : Nasdaq ... 09:00 AM. STSS : Nasdaq AREC : Nasdaq RVPH : Nasdaq. Sharps Technology, Reviva ...https://sharpstechnology.com. Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...The latest price target for . Sharps Technology (NASDAQ: STSS) was reported by Aegis Capital on May 9, 2023.The analyst firm set a price target for $16.00 expecting STSS to rise to within 12 ...Find the latest Insider Activity data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.

Sharp Technology (NASDAQ:STSS) soared 13% on Tuesday as the medical device company announced a deal to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility.

Shares of Sharps Technology, Inc. (NASDAQ:STSS) were down 35% to $0.5301 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules. ...

0.4079. -2.88%. You can practice and explore trading STSS stock methods without spending real money on the virtual paper trading platform. Webull offers Sharps Tech …Nov 16, 2023 · Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ... CHICAGO, Ill. (USA), November 1, 2005 – SPSS Inc. (NASDAQ: SPSS), a worldwide provider of predictive analytics software, today announced results for the quarter ended September 30, 2005. The company reported its fourth consecutive quarter of record revenues, with third quarter 2005 net revenues of $58.3 million, compared to $53.5 …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...The latest price target for Sharps Technology ( NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023. The analyst firm set a price target for 16.00 expecting STSS to rise to within ...

The latest price target for . Sharps Technology (NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023.The analyst firm set a price target for 16.00 expecting STSS to rise to within ...NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...https://sharpstechnology.com. Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.STSSNASDAQ STSSNASDAQ 0.4428USD −0.0072 −1.60% Last update at Nov 22, 13:00 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast STSS …STSS: Sharps Technology Inc Stock Price Quote - NASDAQ CM - Bloomberg Subscribe S&P 500 4,552.25 –0.16% Nasdaq 14,268.21 +0.12% Crude Oil 74.90 …NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented, best-in ...NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as Vice President of Technical Operations. In his role, Mr. Page will be responsible …

NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ...STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the mark...

... Technology Inc (STSS). Sharps Technology Inc (STSS). 0.4700 +0.0002 (+0.04%) 12/01/23 [NASDAQ]. N/A x N/A N/A x N/A. Realtime by (Cboe BZX). N/A x N/A N/A x N/A.Find the latest Insider Activity data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement. NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, …NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, today announced the closing of its initial public offering of 3,750,000 units at a public offering price of $4.25 …NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ...The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...STSS Sharps Technology Inc Current Report Filing (8-k) 0001737995 false 0001737995 2023-02-01 2023-02-01 0001737995 STS...NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...10-Year Purchase Agreement: As a result of the proposed acquisition of InjectEZ, Nephron has agreed to a 10-year Purchase Agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 ...

Jan 30, 2023 · By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets. The company operates two primary syringe-based platforms which includes pre-filled syringes and smart safety syringes. In November 2022, Sharps entered into an impactful manufacturing and research

Sharps Technology stock was originally listed at a price of $2.11 in Apr 14, 2022. If you had invested in Sharps Technology stock at $2.11, your return over the last 1 years would have been -77.73%, for an annualized return of -77.73% (not including any dividends or dividend reinvestments).

Sep 29, 2023 · STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of ... Sep 29, 2023 · ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American ... At Cannae Holdings, a filing with the SEC revealed that on Monday, Director Barry B. Moullet bought 1,000 shares of CNNE, for a cost of $23.06 each, for a total investment of $23,064. So far ...06/30/2022. 26. 26. New. $0. 1. Back to STSS Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major ...Apr 4, 2023 · NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ... NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...Short interest for Sharps Technology gives investors a sense of the degree to which investors are betting on the decline of Sharps Technology's stock. Short interest data is updated every two weeks.Stock analysis for Sharps Technology Inc (STSS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Jan 13, 2023 · NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ... NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Great news for Sharps Technology, Inc. (NASDAQ:STSS): Insiders acquired stock in large numbers last year. Get the latest Sharps Technology, Inc. (STSS) stock news and headlines to help you in your ... Instagram:https://instagram. sale used xbox 360best conventional loan lendersstock winners of the dayvanguard core bond fund Nov 17, 2023 · markets.businessinsider.com - September 15 at 10:14 AM. Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying. benzinga.com - September 10 at 7:40 AM. Multiple insiders bought Sharps Technology, Inc. (NASDAQ:STSS) stock earlier this year, a positive sign for shareholders. finance.yahoo.com - July 15 at 8:36 AM. petrobas stockdj utility index NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ... what is bnd 10-Year Purchase Agreement: As a result of the proposed acquisition of InjectEZ, Nephron has agreed to a 10-year Purchase Agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 ...The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...